Back to top
more

Aurinia Pharmaceuticals (AUPH)

(Real Time Quote from BATS)

$8.16 USD

8.16
932,374

-0.22 (-2.63%)

Updated Nov 13, 2024 02:40 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 24% (61 out of 250)

Industry: Medical - Drugs

Zacks News

Is a Surprise Coming for Aurinia Pharmaceuticals (AUPH) This Earnings Season?

Investors are always looking for stocks that are poised to beat at earnings season and Aurinia Pharmaceuticals Inc. (AUPH) may be one such company.

    What's in the Cards for Repros (RPRX) this Earnings Season?

    Repros Therapeutics Inc. (RPRX) is expected to report first-quarter 2017 results this month. Let's see how things are shaping up for this quarter.

      Will Intrexon (XON) Pull Off a Surprise in Q1 Earnings?

      Intrexon Corporation (XON) is expected to report first-quarter 2017 results on May 9.

        Implied Volatility Surging for Aurinia Pharmaceuticals(AUPH) Stock Options

        Implied Volatility Surging for Aurinia Pharmaceuticals(AUPH) Stock makes it lucrative to the option traders.

          Anupriya Datta headshot

          Is the Options Market Predicting a Spike in Aurinia Pharmaceuticals (AUPH) Stock?

          Investors in Aurinia Pharmaceuticals Inc. (AUPH) need to pay close attention to the stock based on moves in the options market lately.

            Aurinia (AUPH) Catches Eye: Stock Moves up 8.5% in Session

            Aurinia Pharmaceuticals Inc. (AUPH) moved big last session, as its shares rose above 8% on the day.

              Aurinia Pharmaceuticals (AUPH) Shares March Higher, Can It Continue?

              Aurinia Pharmaceuticals Inc. (AUPH) has been on the move lately as the stock has risen by 41.8% in the past four weeks, and it is currently trading well above its 20-Day SMA

                Can The Uptrend Continue for Aurinia Pharmaceuticals (AUPH)?

                Investors certainly have to be happy with Aurinia Pharmaceuticals Inc. (AUPH) and its short term performance

                  Aurinia Pharmaceuticals (AUPH) Jumps: Stock Rises 5.6%

                  Aurinia Pharmaceuticals Inc. (AUPH) moved big last session, as its shares jumped almost 6% on the day.

                    Implied Volatility Surging for Aurinia Pharmaceuticals (AUPH) Stock Options

                    Investors in Aurinia Pharmaceuticals Inc. (AUPH) need to pay close attention to the stock based on moves in the options market lately.